Literature DB >> 32678314

A quality improvement initiative to implement the eat, sleep, console neonatal opioid withdrawal syndrome care tool in Massachusetts' PNQIN collaborative.

Elisha M Wachman1, Mary Houghton2, Patrice Melvin3, Breanna C Isley4, Jennifer Murzycki5, Rachana Singh6, Susan Minear4, Kathryn Dee L MacMillan7, Debra Banville8, Amy Walker9, Teresa Mitchell10, Rose Galimi-Hayes11, Selena Jorgensen12, Daphne Remy Gomes13, Fran Hodgins14, Bonny L Whalen15, Hafsatou Diop16, Munish Gupta2.   

Abstract

OBJECTIVE: To support hospitals in the Massachusetts PNQIN collaborative with adoption of the ESC Neonatal Opioid Withdrawal Syndrome (NOWS) Care Tool© and assess NOWS hospitalization outcomes. STUDY
DESIGN: Statewide QI study where 11 hospitals adopted the ESC NOWS Care Tool©. Outcomes of pharmacotherapy and length of hospital stay (LOS) and were compared in Pre- and Post-ESC implementation cohorts. Statistical Process Control (SPC) charts were used to examine changes over time.
RESULTS: The Post-ESC group had lower rates of pharmacotherapy (OR 0.35, 95% CI 0.26, 0.46) with shorter LOS (RR 0.79, 95% CI 0.76, 0.82). The 30-day NOWS readmission rate was 1.2% in the Pre- and 0.4% in the Post-ESC cohort. SPC charts indicate a shift in pharmacotherapy from 54.8 to 35.0% and LOS from 14.2 to 10.9 days Post-ESC.
CONCLUSIONS: The ESC NOWS Care Tool was successfully implemented across a state collaborative with improvement in NOWS outcomes without short-term adverse effects.

Entities:  

Year:  2020        PMID: 32678314     DOI: 10.1038/s41372-020-0733-y

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  2 in total

1.  Neonatal abstinence syndrome: assessment and management.

Authors:  L P Finnegan; J F Connaughton; R E Kron; J P Emich
Journal:  Addict Dis       Date:  1975

2.  Impact of Parental Presence at Infants' Bedside on Neonatal Abstinence Syndrome.

Authors:  Mary Beth Howard; Davida M Schiff; Nicole Penwill; Wendy Si; Anjali Rai; Tahlia Wolfgang; James M Moses; Elisha M Wachman
Journal:  Hosp Pediatr       Date:  2017-02
  2 in total
  5 in total

1.  Racial and Ethnic Disparities in Maternal and Infant Outcomes Among Opioid-Exposed Mother-Infant Dyads in Massachusetts (2017-2019).

Authors:  Mary Peeler; Munish Gupta; Patrice Melvin; Allison S Bryant; Hafsatou Diop; Ronald Iverson; Katherine Callaghan; Elisha M Wachman; Rachana Singh; Mary Houghton; Shelly F Greenfield; Davida M Schiff
Journal:  Am J Public Health       Date:  2020-10-15       Impact factor: 9.308

Review 2.  Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants.

Authors:  Lori A Devlin; Leslie W Young; Walter K Kraft; Elisha M Wachman; Adam Czynski; Stephanie L Merhar; T Winhusen; Hendrée E Jones; Brenda B Poindexter; Lauren S Wakschlag; Amy L Salisbury; Abigail G Matthews; Jonathan M Davis
Journal:  J Perinatol       Date:  2021-09-23       Impact factor: 3.225

3.  Pharmacological Prevention of Neonatal Opioid Withdrawal in a Pregnant Guinea Pig Model.

Authors:  Alireza Safa; Allison R Lau; Sydney Aten; Karl Schilling; Karen L Bales; Victoria A Miller; Julie Fitzgerald; Min Chen; Kasey Hill; Kyle Dzwigalski; Karl Obrietan; Mitch A Phelps; Wolfgang Sadee; John Oberdick
Journal:  Front Pharmacol       Date:  2021-02-25       Impact factor: 5.810

4.  Establishing evidence-based pharmacologic treatments for neonatal abstinence syndrome: A retrospective case study.

Authors:  Sarah K Brewer; Jonathan M Davis; Rachana Singh; Lisa C Welch
Journal:  J Clin Transl Sci       Date:  2022-07-25

5.  Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.

Authors:  Katherine Sullivan; Mandy B Belfort; Patrice Melvin; Asimenia Angelidou; Aviel Peaceman; Jessica E Shui; Ruben Vaidya; Rachana Singh; Ruby Bartolome; Silvia Patrizi; Neha Chaudhary; Ilona Telefus Goldfarb; Ivana Culic; Diana Yanni; Munish Gupta; Mark Hudak; Margaret G Parker
Journal:  J Perinatol       Date:  2021-07-05       Impact factor: 2.521

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.